{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:18:08Z","timestamp":1792793888014,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of Fujian Province, China.","award":[".(2022J02037"],"award-info":[{"award-number":[".(2022J02037"]}]},{"DOI":"10.13039\/501100017686","name":"Fujian provincial health technology project","doi-asserted-by":"crossref","award":["2021CXA011"],"award-info":[{"award-number":["2021CXA011"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Excellent Young Scholars Cultivation Project of Fujian Medical University Union Hospital","award":["2022XH034Z"],"award-info":[{"award-number":["2022XH034Z"]}]},{"name":"Fujian Provincial Natural Science Foundation of China","award":["2020J011014"],"award-info":[{"award-number":["2020J011014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72818-w","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T06:02:31Z","timestamp":1726466551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Validation of a genome-based model for adjusting radiotherapy dose (GARD) in patients with locally advanced rectal cancer"],"prefix":"10.1038","volume":"14","author":[{"given":"Huang","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yineng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"issue":"3","key":"72818_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality Worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71(3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"72818_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/jan.13443","volume":"74","author":"TY Chiang","year":"2018","unstructured":"Chiang, T. Y. et al. Colorectal cancer in Taiwan: A case-control retrospective analysis of the impact of a case management programme on refusal and discontinuation of treatment. J. Adv. Nurs.74(2), 395\u2013406 (2018).","journal-title":"J. Adv. Nurs."},{"key":"72818_CR3","doi-asserted-by":"crossref","unstructured":"Hsu, S. H. et al. The association between hypertriglyceridemia and colorectal cancer: A long-term community cohort study in Taiwan. Int. J. Environ. Res. Public. Health19(13), (2022).","DOI":"10.3390\/ijerph19137804"},{"issue":"4","key":"72818_CR4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa2303269","volume":"389","author":"D Schrag","year":"2023","unstructured":"Schrag, D. et al. Preoperative treatment of locally advanced rectal cancer. N Engl. J. Med.389(4), 322\u2013334 (2023).","journal-title":"N Engl. J. Med."},{"issue":"3","key":"72818_CR5","doi-asserted-by":"publisher","first-page":"e055140","DOI":"10.1136\/bmjopen-2021-055140","volume":"12","author":"T Akiyoshi","year":"2022","unstructured":"Akiyoshi, T. et al. Non-operative management after chemoradiotherapy plus consolidation or sandwich (induction with bevacizumab and consolidation) chemotherapy in patients with locally advanced rectal cancer: A multicentre, randomised phase II trial (NOMINATE trial). BMJ Open.12(3), e055140 (2022).","journal-title":"BMJ Open."},{"issue":"6","key":"72818_CR6","first-page":"619","volume":"10","author":"K Sato","year":"2019","unstructured":"Sato, K. et al. Comparable regional therapeutic effects between neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy for locally advanced lower rectal cancer in terms of histopathological analysis. Mol. Clin. Oncol.10 (6), 619\u2013624 (2019).","journal-title":"Mol. Clin. Oncol."},{"key":"72818_CR7","doi-asserted-by":"publisher","first-page":"104196","DOI":"10.1016\/j.critrevonc.2023.104196","volume":"192","author":"L Boublikova","year":"2023","unstructured":"Boublikova, L. et al. Total neoadjuvant therapy in rectal cancer: The evidence and expectations. Crit. Rev. Oncol. Hematol.192, 104196 (2023).","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4","key":"72818_CR8","first-page":"620","volume":"279","author":"W Lin","year":"2024","unstructured":"Lin, W. et al. Surgical outcomes in total neoadjuvant therapy for rectal cancer versus standard long-course chemoradiation: A systematic review and meta-analysis of randomized controlled trials. Ann. Surg.279(4), 620\u2013630 (2024).","journal-title":"Ann. Surg."},{"issue":"5","key":"72818_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11888-015-0285-2","volume":"11","author":"TJ George","year":"2015","unstructured":"George, T. J., Allegra, C. J. & Yothers, G. Neoadjuvant rectal (NAR) score: A new surrogate endpoint in rectal cancer clinical trials. Curr. Colorectal Cancer Rep.11(5), 275\u2013280 (2015).","journal-title":"Curr. Colorectal Cancer Rep."},{"key":"72818_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.sopen.2024.01.009","volume":"18","author":"AM Troester","year":"2024","unstructured":"Troester, A. M. & Gaertner, W. B. Contemporary management of rectal cancer. Surg. Open. Sci.18, 17\u201322 (2024).","journal-title":"Surg. Open. Sci."},{"issue":"1","key":"72818_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1245\/s10434-015-4836-1","volume":"23","author":"MR Weiser","year":"2016","unstructured":"Weiser, M. R. Rectal cancer: Time for precision medicine?. Ann. Surg. Oncol.23(1), 12\u201315 (2016).","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"72818_CR12","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.2337\/dc16-0541","volume":"39","author":"JE Fradkin","year":"2016","unstructured":"Fradkin, J. E., Hanlon, M. C. & Rodgers, G. P. NIH precision medicine initiative: Implications for diabetes research. Diabetes Care39(7), 1080\u20131084 (2016).","journal-title":"Diabetes Care"},{"issue":"5","key":"72818_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ctrv.2015.02.009","volume":"41","author":"N Roper","year":"2015","unstructured":"Roper, N. et al. The landscape of precision cancer medicine clinical trials in the United States. Cancer Treat. Rev.41 (5), 385\u2013390 (2015).","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"72818_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13014-020-01695-0","volume":"15","author":"F Roeder","year":"2020","unstructured":"Roeder, F. et al. Recent advances in (chemo-)radiation therapy for rectal cancer: A comprehensive review. Radiat. Oncol.15(1), 262 (2020).","journal-title":"Radiat. Oncol."},{"issue":"1","key":"72818_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2014.08.035","volume":"113","author":"JP Burbach","year":"2014","unstructured":"Burbach, J. P. et al. Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: A systematic review and meta-analysis. Radiother Oncol.113(1), 1\u20139 (2014).","journal-title":"Radiother Oncol."},{"issue":"04","key":"72818_CR16","first-page":"390","volume":"19","author":"Shenghui","year":"2016","unstructured":"Shenghui, et al. Factors influencing delayed anastomotic leakage and clinical characteristics after rectal cancer preservation surgery. Chin. J. Gastrointest. Surg.19(04), 390\u2013395 (2016).","journal-title":"Chin. J. Gastrointest. Surg."},{"issue":"11","key":"72818_CR17","first-page":"1092","volume":"18","author":"C Pan","year":"2015","unstructured":"Pan, C. et al. Diagnosis and treatment of pelvic wall and intestinal fibrosis with low bowel obstruction after neoadjuvant chemoradiotherapy for rectal cancer. Chin. J. Gastrointest. Surg.18(11), 1092\u20131097 (2015).","journal-title":"Chin. J. Gastrointest. Surg."},{"key":"72818_CR18","doi-asserted-by":"crossref","unstructured":"Situ, Y. et al. MRN (MRE11-RAD50-NBS1) complex in human cancer and prognostic implications in colorectal cancer. Int. J. Mol. Sci.20(4), (2019).","DOI":"10.3390\/ijms20040816"},{"issue":"7457","key":"72818_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 499 (7457), 214\u2013218 (2013).","journal-title":"Nature"},{"key":"72818_CR20","doi-asserted-by":"publisher","first-page":"153303382311784","DOI":"10.1177\/15330338231178403","volume":"22","author":"A Dey","year":"2023","unstructured":"Dey, A. et al. Recent advancements, limitations, and future perspectives of the use of personalized medicine in treatment of colon cancer. Technol. Cancer Res. Treat.22, 15330338231178404 (2023).","journal-title":"Technol. Cancer Res. Treat."},{"issue":"2","key":"72818_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ijrobp.2009.05.056","volume":"75","author":"S Eschrich","year":"2009","unstructured":"Eschrich, S. et al. Systems biology modeling of the radiation sensitivity network: A biomarker discovery platform. Int. J. Radiat. Oncol. Biol. Phys.75(2), 497\u2013505 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"72818_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12967-023-04029-2","volume":"21","author":"P Zhao","year":"2023","unstructured":"Zhao, P. et al. Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets. J. Transl Med.21 (1), 176 (2023).","journal-title":"J. Transl Med."},{"issue":"4","key":"72818_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/annonc\/mdz052","volume":"30","author":"E Fontana","year":"2019","unstructured":"Fontana, E. et al. Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials. Ann. Oncol.30 (4), 520\u2013527 (2019).","journal-title":"Ann. Oncol."},{"issue":"16","key":"72818_CR24","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.1158\/0008-5472.CAN-05-0656","volume":"65","author":"JF Torres-Roca","year":"2005","unstructured":"Torres-Roca, J. F. et al. Prediction of radiation sensitivity using a gene expression classifier. Cancer Res.65 (16), 7169\u20137176 (2005).","journal-title":"Cancer Res."},{"issue":"33","key":"72818_CR25","doi-asserted-by":"publisher","first-page":"34414","DOI":"10.18632\/oncotarget.5437","volume":"6","author":"KA Ahmed","year":"2015","unstructured":"Ahmed, K. A. et al. The radiosensitivity index predicts for overall survival in glioblastoma. Oncotarget. 6 (33), 34414\u201334422 (2015).","journal-title":"Oncotarget"},{"issue":"1","key":"72818_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.radonc.2015.07.018","volume":"117","author":"T Strom","year":"2015","unstructured":"Strom, T. et al. Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer. Radiother Oncol.117 (1), 159\u2013164 (2015).","journal-title":"Radiother Oncol."},{"issue":"3","key":"72818_CR27","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ijrobp.2015.06.021","volume":"93","author":"JF Torres-Roca","year":"2015","unstructured":"Torres-Roca, J. F. et al. Integration of a radiosensitivity molecular signature into the assessment of local recurrence risk in breast cancer. Int. J. Radiat. Oncol. Biol. Phys.93(3), 631\u2013638 (2015).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"72818_CR28","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ijrobp.2015.01.036","volume":"92","author":"KA Ahmed","year":"2015","unstructured":"Ahmed, K. A. et al. Differences between colon cancer primaries and metastases using a molecular assay for tumor radiation sensitivity suggest implications for potential oligometastatic SBRT patient selection. Int. J. Radiat. Oncol. Biol. Phys.92(4), 837\u2013842 (2015).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"72818_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","volume":"18","author":"JG Scott","year":"2017","unstructured":"Scott, J. G. et al. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. Lancet Oncol.18 (2), 202\u2013211 (2017).","journal-title":"Lancet Oncol."},{"issue":"30","key":"72818_CR30","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.2217\/fon-2020-0060","volume":"16","author":"Z Yuan","year":"2020","unstructured":"Yuan, Z. et al. Modeling precision genomic-based radiation dose response in rectal cancer. Fut. Oncol.16(30), 2411\u20132420 (2020).","journal-title":"Fut. Oncol."},{"key":"72818_CR31","doi-asserted-by":"publisher","first-page":"1154222","DOI":"10.3389\/fonc.2023.1154222","volume":"13","author":"J Tobiasz","year":"2023","unstructured":"Tobiasz, J. et al. Multivariate piecewise linear regression model to predict radiosensitivity using the association with the genome-wide copy number variation. Front. Oncol.13, 1154222 (2023).","journal-title":"Front. Oncol."},{"key":"72818_CR32","doi-asserted-by":"crossref","unstructured":"Qin, F. et al. A novel high-risk model identified by epithelial-mesenchymal transition predicts prognosis and radioresistance in rectal cancer. Mol. Carcinog., (2024).","DOI":"10.1002\/mc.23797"},{"key":"72818_CR33","doi-asserted-by":"publisher","first-page":"105228","DOI":"10.1016\/j.ebiom.2024.105228","volume":"106","author":"E Domingo","year":"2024","unstructured":"Domingo, E. et al. Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFbeta as key predictors. EBioMedicine. 106, 105228 (2024).","journal-title":"EBioMedicine"},{"issue":"16","key":"72818_CR34","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1200\/JCO.2014.60.1054","volume":"33","author":"JJ Smith","year":"2015","unstructured":"Smith, J. J. & Garcia-Aguilar, J. Advances and challenges in treatment of locally advanced rectal cancer. J. Clin. Oncol.33 (16), 1797\u20131808 (2015).","journal-title":"J. Clin. Oncol."},{"key":"72818_CR35","doi-asserted-by":"crossref","unstructured":"Amin, M. B. et al. The Eighth Edition AJCC Cancer staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging. pp. 93\u201399. (2017).","DOI":"10.3322\/caac.21388"},{"key":"72818_CR36","unstructured":"Hall, E. J. & Giaccia, A. J. Radiobiology for the RadiologistVol. 6 (Lippincott Williams & Wilkins, 2006)."},{"issue":"14","key":"72818_CR37","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1088\/0031-9155\/58\/14\/4897","volume":"58","author":"J Jeong","year":"2013","unstructured":"Jeong, J., Shoghi, K. I. & Deasy, J. O. Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response. Phys. Med. Biol.58 (14), 4897\u20134919 (2013).","journal-title":"Phys. Med. Biol."},{"key":"72818_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-14-153","volume":"14","author":"EA Welsh","year":"2013","unstructured":"Welsh, E. A. et al. Iterative rank-order normalization of gene expression microarray data. BMC Bioinform.14, 153 (2013).","journal-title":"BMC Bioinform."},{"issue":"2","key":"72818_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad, B. M. et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 19 (2), 185\u2013193 (2003).","journal-title":"Bioinformatics"},{"issue":"2","key":"72818_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5114\/jcb.2023.127051","volume":"15","author":"A Saeedian","year":"2023","unstructured":"Saeedian, A. et al. Complication and response assessment of high-dose-rate endorectal brachytherapy boost in neo-adjuvant chemoradiotherapy of locally advanced rectal cancer with long-term outcomes. J. Contemp. Brachytherapy. 15 (2), 117\u2013122 (2023).","journal-title":"J. Contemp. Brachytherapy"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72818-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72818-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72818-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T06:04:15Z","timestamp":1726466655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72818-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72818"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72818-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"19 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Fujian Medical University Union Hospital. All patients had written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"21572"}}